Oregon State University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Oregon State University sits in the top decile of US sponsors by registered trial count (#500 of 15,742 sponsors by registered trial count).

33 total trials 4 currently recruiting 22 completed early-phase tilt top decile by trial count

Oregon State University: 33 sponsored US clinical trials, 4 recruiting.

Oregon State University sponsors 33 registered US clinical trials on ClinicalTrials.gov, 4 of them currently recruiting, and 22 completed. 2 of these trials are in Phase 3-4 (later-stage) and 8 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Environmental Exposure, with 2 trials.

Top-decile sponsor footprint

Oregon State University ranks in the top decile of sponsors by registered trial count (#500 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 69/100

22 of 24 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

33 total, page 1 of 1

RECRUITING Phase 1

Virtual Mindful After Cancer (MAC) Intervention to Promote Sexual Health for Breast and Gynecologic Cancer Survivors

NCT07055854

RECRUITING NA

Effect of Walnuts on Cognitive Function and Gut Microbiome in Older Adults

NCT06942351

RECRUITING NA

Shift Worker Intervention for Sleep Health

NCT06384742

RECRUITING NA

Optimizing Sleep Health in Nurses

NCT05965609

ACTIVE NOT RECRUITING NA

Almonds to Improve Gut Health and Decrease Inflammation

NCT05790564

ACTIVE NOT RECRUITING Phase 4

Use of Empagliflozin to Treat Prediabetes

NCT05426525

ACTIVE NOT RECRUITING NA

Scalability of a Home Health Navigator Program to Reduce Arsenic, Nitrate, and Lead in Private Well Water

NCT05395663

ACTIVE NOT RECRUITING NA

Discovery of Biological Signatures for Cruciferous Vegetable Intake (Single Serving)

NCT04641026

ACTIVE NOT RECRUITING NA

Multi-site Animal Assisted Intervention for Children With DD and Their Family Dog

NCT04799119

COMPLETED NA

Development and Evaluation CAT and Youth

NCT05950672

COMPLETED NA

Effect of Daily Consumption of Glycomacropeptide on Gut Microbiome and Blood Functional Proteome of Subjects With Irritable Bowel Syndrome

NCT05482464

COMPLETED NA

The Effect of Galactooligosaccharides (GOS) on the Gut Microbiota of Lactose Intolerance Individuals

NCT06915129

COMPLETED NA

Opening the Conversation Study

NCT04806724

TERMINATED NA

Insulin and Muscle Fat Metabolism

NCT04759872

COMPLETED NA

Mitochondrial Remodeling After Exercise

NCT04103424

COMPLETED NA

Mindful After Cancer: A Mindfulness-based Therapy Intervention for Sexual Health After Cancer

NCT04559854

COMPLETED Early Phase 1

Pharmacokinetics of Benzo[a]Pyrene: Impact of Diet

NCT03802721

COMPLETED Early Phase 1

Ultralow Dose PAH Binary Mixture Study

NCT03631667

COMPLETED NA

Role of Centrum® Silver® in Improving Micronutrient Status in Older Men

NCT03004807

COMPLETED Early Phase 1

Benzo[a]Pyrene Ultralow Dose-Response Study

NCT03318978

TERMINATED NA

The Effects of Kinesio Tape® on Arthrogenic Muscle Inhibition and Rate of Torque Development

NCT03472924

COMPLETED NA

Sensory Perception of Sweet Flavors in E-Cigarette

NCT03332953

COMPLETED NA

Imitation-based Dog Assisted Intervention, for Children With Developmental Disabilities.

NCT03462407

COMPLETED Phase 4

Human Oral Detection of Glucose Olygomers

NCT02589353

COMPLETED NA

The Effect of Combinatorial Nutritional Supplementation on Immune Function in Healthy Older Adults

NCT02876315

COMPLETED NA

Exercise and Insulin Signaling in Human Skeletal Muscle

NCT02987491

COMPLETED NA

Role of Hazelnut Consumption in Improving Micronutrient Status in Older Adults

NCT03485989

COMPLETED Phase 1

Xanthohumol and Prevention of DNA Damage

NCT02432651

COMPLETED Phase 2

The Role of R-Alpha Lipoic Acid in the Treatment of Atherosclerotic Vascular Disease

NCT00764270

COMPLETED

Xanthohumol and Metabolic Syndrome

NCT01367431

COMPLETED Phase 1

Lipoic Acid and Prevention of Heart Disease

NCT00765310

COMPLETED NA

Randomized Trial of the Positive Action Program in Chicago Schools and Extension to Grade 8

NCT01025674

COMPLETED Phase 2

Effects of Jumping on Growing Bones

NCT00000405

What is open in the Oregon State University pipeline

4 recruiting of 33 indexed (12% open); 22 completed (67%).

Phase mix: 2 late (III/IV) vs 8 early (I/II) (early-phase heavy).

Top condition: Environmental Exposure (2 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Oregon State University: open-pipeline peers nationwide

Peers matched on 33 registered trials and 12% open enrollment, not the therapeutic-area sidebar.

Oregon State University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 20406080100 0%5%10%15%20% Total trials Recruiting share Oregon State UniversityAclaris TherapeuticsAntonios LikourezosBaylor UniversityBecton, Dickinson and CompanyUniversity of Massachusetts, AmherstUniversity of Missouri, Kansas CityNational Institute of Dental and Craniofacial Research (NIDCR)East Carolina University
Oregon State University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Oregon State University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 33 trials (± recruiting share)

Sponsors near 12% open enrollment (± trial volume)

What to do with this Oregon State University page

33 registered trials is a research-attention snapshot, not an endorsement of Oregon State University or any single study.

  • 4 of Oregon State University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Environmental Exposure is the condition Oregon State University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Environmental Exposure trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Oregon State University pipeline card: 33 registered trials from official public datasets.Report a data error.